Tumour microenvironment immune markers associated with pathologic response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer (Pure-01 trial: an open label, single arm, Phase II study)
VIRCHOWS ARCHIV（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined